A. Paccagnella

656 total citations
32 papers, 502 citations indexed

About

A. Paccagnella is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, A. Paccagnella has authored 32 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in A. Paccagnella's work include Lung Cancer Treatments and Mutations (8 papers), Cancer Treatment and Pharmacology (7 papers) and Head and Neck Cancer Studies (6 papers). A. Paccagnella is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Cancer Treatment and Pharmacology (7 papers) and Head and Neck Cancer Studies (6 papers). A. Paccagnella collaborates with scholars based in Italy, United States and Australia. A. Paccagnella's co-authors include Alessandro Gava, L. Loreggian, L. Tomio, Giovanni Pappagallo, Carlo A. Mione, C. Marchiori, Mario V. Fiorentino, G Pizzi, Piotr Ponikowski and Antonio Jirillo and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

A. Paccagnella

30 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Paccagnella Italy 12 251 186 174 163 61 32 502
Lihua Dong China 14 131 0.5× 79 0.4× 105 0.6× 66 0.4× 99 1.6× 27 410
Hiroshi Nakade Japan 13 207 0.8× 233 1.3× 245 1.4× 18 0.1× 44 0.7× 31 456
Satoshi Hamauchi Japan 17 360 1.4× 266 1.4× 234 1.3× 191 1.2× 78 1.3× 71 697
Diclehan Ünsal Türkiye 10 98 0.4× 64 0.3× 128 0.7× 83 0.5× 55 0.9× 21 328
Rafael Aguiló Spain 11 588 2.3× 81 0.4× 281 1.6× 22 0.1× 92 1.5× 31 779
Ernst J. Smid Netherlands 12 149 0.6× 128 0.7× 131 0.8× 337 2.1× 26 0.4× 25 655
Hyun Jik Lee South Korea 14 322 1.3× 331 1.8× 316 1.8× 11 0.1× 46 0.8× 29 603
Isao Kumano Japan 14 397 1.6× 391 2.1× 110 0.6× 12 0.1× 22 0.4× 31 609
A. Norton United Kingdom 8 290 1.2× 61 0.3× 173 1.0× 24 0.1× 63 1.0× 13 628

Countries citing papers authored by A. Paccagnella

Since Specialization
Citations

This map shows the geographic impact of A. Paccagnella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Paccagnella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Paccagnella more than expected).

Fields of papers citing papers by A. Paccagnella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Paccagnella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Paccagnella. The network helps show where A. Paccagnella may publish in the future.

Co-authorship network of co-authors of A. Paccagnella

This figure shows the co-authorship network connecting the top 25 collaborators of A. Paccagnella. A scholar is included among the top collaborators of A. Paccagnella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Paccagnella. A. Paccagnella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Casadei, Beatrice, A. Paccagnella, Andrea Farolfi, et al.. (2021). FDG‐PET IMAGING AND RADIOMICS IN RESPONSE ASSESSMENT OF LYMPHOMA PATIENTS UNDERGOING CAR T‐CELL THERAPY. Hematological Oncology. 39(S2). 1 indexed citations
2.
Paccagnella, A., Maria Sambataro, Alessandra Mauri, et al.. (2014). Analysis and Improvement of Organizational Models for the Management of Patients With Type 2 Diabetes Mellitus. Quality Management in Health Care. 23(2). 99–118. 1 indexed citations
3.
Baruffi, Carla, et al.. (2012). Nutritional intervention for amyotrophic lateral sclerosis.. PubMed. 58(3). 253–60. 8 indexed citations
4.
Blanchard, Pierre, Abderrahmane Bourredjem, Jean Bourhis, et al.. (2011). TAXANE-CISPLATIN-5FU AS INDUCTION CHEMOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA: AN INDIVIDUAL PATIENT DATA META-ANALYSIS OF THE MACH-NC GROUP. Radiotherapy and Oncology. 98. S6–S6. 7 indexed citations
5.
Rea, Federico, Adolfo Favaretto, Giuseppe Marulli, et al.. (2011). Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of malignant pleural mesothelioma (MPM).. Journal of Clinical Oncology. 29(15_suppl). 7090–7090. 2 indexed citations
6.
Anker, Stefan D., Gerasimos Filippatos, John McLaughlin, et al.. (2009). ESPEN Guidelines on Parenteral Nutrition: On Cardiology and Pneumology. Clinical Nutrition. 28(4). 455–460. 53 indexed citations
7.
Paccagnella, A., et al.. (2007). Biopsychosocial approach to home enteral nutrition: measure of subjective satisfaction and quality of life.. PubMed. 98(1). 5–17. 11 indexed citations
9.
Paccagnella, A., G Cavaniglia, L. Loreggian, et al.. (2004). Randomized Phase III Trial of Neoadjuvant Chemotherapy in Head and Neck Cancer: 10-Year Follow-Up. JNCI Journal of the National Cancer Institute. 96(22). 1714–1717. 143 indexed citations
10.
Loreggian, L., A. Paccagnella, Alessandro Gava, et al.. (2004). Randomized phase III trial of neoadjuvant chemotherapy (CT) in head and neck (H&N) cancer patients: An update based on 10 years' follow up. Journal of Clinical Oncology. 22(14_suppl). 5532–5532. 3 indexed citations
11.
Favaretto, Adolfo, Andrea Ardizzoni, Lucia Tixi, et al.. (2000). Full dose (FD) chemotherapy (CT) plus lenograstim and low dose (LD) CT in elderly SCLC patients. A phase II randomized fonicap-GSTPV study. Lung Cancer. 29(1). 9–9. 2 indexed citations
12.
Crinò, Lucio, M. Marangolo, F. Figoli, et al.. (1995). 1064 Gemcitabine-cisplatin combination in non-small cell lung cancer (NSCLC). A phase II study. European Journal of Cancer. 31. S222–S222. 12 indexed citations
13.
Paccagnella, A., et al.. (1994). The Effects of Prolonged Cardiopulmonary Bypass on Cell-Mediated Immunity. The Thoracic and Cardiovascular Surgeon. 42(1). 14–20. 9 indexed citations
14.
Ihde, Daniel C., David Ball, R. Arriagada, et al.. (1994). Postoperative adjuvant therapy for non-small cell lung cancer: a consensus report. Lung Cancer. 11. S15–S17. 8 indexed citations
15.
Tomio, L., A. Paccagnella, Lucio Loreggian, et al.. (1993). A Pilot Study of Concomitant Radiation and Chemotherapy in Patients with Locally Advanced Head and Neck Cancer. American Journal of Clinical Oncology. 16(3). 264–267. 6 indexed citations
16.
Martignone, Stefania, Sylvie Ménard, Amedeo Vittorio Bedini, et al.. (1993). Study of the expression and function of the tumour-associated antigen CaMBr1 in small cell lung carcinomas. European Journal of Cancer. 29(14). 2020–2025. 14 indexed citations
17.
Paccagnella, A., Licia Turolla, G. Zanardo, et al.. (1989). Fatal Progression of Behçet's Disease after Cardiac Surgery. The Thoracic and Cardiovascular Surgeon. 37(5). 320–321. 9 indexed citations
18.
Fiorentino, Mario V., Otello Daniele, Paolo Morandi, et al.. (1988). Intrapericardial instillation of platin in malignant pericardial effusion. Cancer. 62(9). 1904–1906. 31 indexed citations
19.
Besi, Pietro De, Vanna Chiarion‐Sileni, Luigi Salvagno, et al.. (1988). Systemic Chemotherapy with Cisplatin, 5-Fluorouracil and Allopurinol in the Management of Advanced Epidermoid Esophageal Cancer. Recent results in cancer research. 110. 196–197. 3 indexed citations
20.
Fornasiero, A., et al.. (1986). Peptichemio in advanced breast cancer: a clinical evaluation in 32 patients.. PubMed. 70(5). 647–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026